First Therapeutic Vaccine for Genital Herpes Reduces Signs of Infection for One Year
A therapeutic vaccine for genital herpes has the potential to reduce viral activity as well as decrease the number of days of recurrent herpes, as observed in a phase II clinical trial.
Read More
What is the Importance of Narrow-spectrum Antibacterial Targets?
Kirk Hevener, PharmD, PhD, explains the importance of narrow-spectrum antibacterial targets.
Watch
What Are Some New Technologies to Detect Antimicrobial Susceptibility & Resistance?
Romney Humphries, PhD, D(ABMM), discusses new technologies to detect antimicrobial susceptibility and resistance that are currently under production.
What is the Current Disease Burden of Neonatal Infections Across the Globe?
Craig Rubens, MD, PhD, co-founder and executive director of GAPPS at Seattle Children’s Hospital, describes the current disease burden of neonatal infections across the globe.
How Does MCA Work and What Differentiates It From Other Analyses?
Andrew Chasteen from Accelerate Diagnostics, Inc, explains Morphokinetic Cellular Analysis (MCA) and how it differs from other analyses.
What Pathogens Are Most Affected by the Colistin-Resistant mcr-1 Gene?
Prof. Andrea Endimiani, MD, PhD, from the Institute of Infectious Diseases at the University of Bern, Switzerland, explains which pathogens are most affected by the colistin resistant mcr-1 gene.
Flint Water Still Under Investigation For Legionella
Research conducted by the Flint Water Study team at Virginia Tech revealed that DNA marker levels for Legionella in the city’s water supply has decreased since October 2015.
